Hideki Amano
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Oncology top 5%
- Lymphatic System and Diseases
Papers in
- Pharmacology 16
- Inflammatory mediators and NSAID effects 16
- Immunology 13
- Immune cells in cancer 4
- Co-authors
- Masataka Majima (52 shared papers)Yoshiya Ito (44 shared papers)Kanako Hosono (31 shared papers)Izumi Hayashi (11 shared papers)Hidero Kitasato (15 shared papers)Shuh Narumiya (14 shared papers)Fumihiro Ogawa (16 shared papers)Yukitoshi Satoh (14 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (13 papers)Cancer Science (3 papers)Laboratory Investigation (3 papers)British Journal of Clinical Pharmacology (2 papers)Journal of Surgical Research (2 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Hideki Amano
72 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 98
- Pharmacology 450
- Oncology 598
- Genetics 217
- Cancer Research 281
- Rehabilitation 110
Countries citing papers authored by Hideki Amano
This map shows the geographic impact of Hideki Amano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Amano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Amano more than expected).
Fields of papers citing papers by Hideki Amano
This network shows the impact of papers produced by Hideki Amano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Amano. The network helps show where Hideki Amano may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Amano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 554 | |
| 2 | 2003 | 290 | |
| 3 | 2008 | 125 | |
| 4 | 2014 | 125 | |
| 5 | 2014 | 82 | |
| 6 | 2003 | 80 | |
| 7 | 2003 | 61 | |
| 8 | 2019 | 58 | |
| 9 | 2009 | 56 | |
| 10 | 2006 | 48 | |
| 11 | 2002 | 43 | |
| 12 | 2012 | 40 | |
| 13 | 2011 | 39 | |
| 14 | 2009 | 34 | |
| 15 | 2012 | 33 | |
| 16 | 2015 | 33 | |
| 17 | 2013 | 31 | |
| 18 | 2013 | 30 | |
| 19 | 2018 | 30 | |
| 20 | 2005 | 29 |
About Hideki Amano
Hideki Amano is a scholar working on Pharmacology, Immunology, Oncology, Genetics and Genetics, having authored 72 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Angiogenesis and VEGF in Cancer (15 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Estrogen and related hormone effects (6 papers), Lymphatic System and Diseases (6 papers), Immune cells in cancer (4 papers), Proteoglycans and glycosaminoglycans research (4 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). The work is most often cited by research in Pharmacology (450 citations), Oncology (598 citations), Genetics (217 citations), Cancer Research (281 citations) and Rehabilitation (110 citations). Hideki Amano has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Masataka Majima, Yoshiya Ito, Kanako Hosono, Izumi Hayashi, Hidero Kitasato, Shuh Narumiya, Fumihiro Ogawa, Yukitoshi Satoh, Hirokuni Yoshimura and Koji Eshima. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cancer Science, Laboratory Investigation, British Journal of Clinical Pharmacology and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.